product1 publisher
Two thirds of Angle Health's $600m round buys out early holders at $2.5bn
The $2.7bn headline price attaches to the $200m Series C. The Wall Street Journal reports the $400m tender offer priced at $2.5bn, and weighting the two puts the whole round nearer $2.57bn. None of the company's growth figures is audited.
Publishers:thenextweb.com
Reality
- Evidence42
- Adoption38
- Hype gap+32
- Incentives78
- Confidence46